glutathione skin whitening evidence review for lightening: a regnant myth or evidence-based verity? Glutathione as a skin‐lightening agent
Description
These annotated unknown reactions were classified into type I and type II
Alongside providing adequate treatment, the patient should be followed up for a few weeks to examine for the resolution and screen for neurological manifestations, as there can be a late manifestation in some patients
However, they can influence symptom severity
52 Further, the safety and tolerability of MSCs as a treatment for AD have been shown in a phase 1 clinical trial
